Poll

Poll results: Do you believe biosimilars have the same efficacy as branded medications?

Results from our recent poll indicate a mixed bag of responses from ophthalmologists.

Ophthalmology Times® polled our audience with the following question from December 3, 2022 to December 16, 2022:​ Do you believe biosimilars have the same efficacy as branded medications?

The poll appeared on OphthalmologyTimes.com and was promoted in our e-newsletters during this time. Results show a mixed bag of responses.

58 responses were recorded, in total. Of these:

43% responded, "Yes."

28% responded, "No."

29% responded, "Unsure."

.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
© 2025 MJH Life Sciences

All rights reserved.